LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News NEWS FLASH L impact Sep 25, 2026, 04:00 PM UTC

Stem Raised to Buy From Neutral by UBS

Ratings actions

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

STEM

Related stories

Freight Traffic for Canadian Railways Continues to Rise — Market Talk Canadian railways for a fourth straight month notched a rise in carloadings in July as strong growth in grains more than made up for large declines in coal and potash. Statistics C L impact | NEWS | Sep 28, 2026, 12:49 PM UTC Telos Corporation Awarded $13.7 Million Contract to Modernize Cyber Risk Management for U.S. Department of Health and Human Services HHS selects full FedRAMP Class D (High)-authorized Xacta suite to modernize enterprise cyber GRC and Authority to Operate processes.ASHBURN, Va., Sept. 28, 2026 (GLOBE NEWSWIRE) L impact | NEWS | Sep 28, 2026, 12:49 PM UTC Transactions under Novonesis’ share buyback program Please read the announcement in PDFAttachment L impact | NEWS | Sep 28, 2026, 12:49 PM UTC Lifecore Biomedical to be Acquired by Webster Equity Partners CHASKA, Minn. and WALTHAM, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. NASDAQ:LFCR today announced that it has entered into a definitive agreement to be acq L impact | NEWS | Sep 28, 2026, 12:49 PM UTC US House Speaker Johnson: We have to remain vigilant against Chinese threat. L impact | NEWS | Sep 28, 2026, 12:49 PM UTC NanoViricides, Inc. (NNVC) Starts Phase II Trial of Oral NV-387 for Ebola NanoViricides began enrolling and dosing patients in a Phase IIA/IIB trial of its oral NV-387 gummies for Ebola in the DRC, with dosing started on or about Sept. 23, 2026.Material L impact | NEWS | Sep 28, 2026, 12:48 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.